Antidepressant Drug Zoloft: Is This A Secure Pharmaceutical Treatment Method?
The pharmaceutical company Pfizer released into the market their new antidepressant product Sertraline hydrochloride bearing the brand names Zoloft and Lustral in the year 1991. This drug is used to treat major depression and is labeled under the Selective Reuptake Inhibitor (SSRI) class of antidepressants. Obsessive-compulsive disorder, panic attacks, social anxiety disorders (social phobia) and post-traumatic stress disorder (PTSD) are some of the psychological disorders treated by Zoloft. All in all, Zoloft apparently shows promise in achieving its role as an effective antidepressant drug. But, the clean image of this antidepressant drug is smeared with intrigues and warnings of some Zoloft complications.
An uproar arose as a consequence for the released advertising propaganda for this antidepressant drug which went like this:"While the cause is unknown, depression may be related to an imbalance of natural chemicals between nerve cells in the brain. Prescription Zoloft works to correct this imbalance. You just shouldn't have to feel this way anymore."The advertisement was met with critiques from medical professionals since the drug does not have sufficient evidence regarding its efficiency to treat depression disorders. The U.S. Food and Drug Administration issued a warning to the pharmaceutical company in response to the issue.
The results from the pre-marketing clinical trials conducted to test the new antidepressant drug Zoloft was met with unsatisfactory results. It was discovered in the placebo study that the drug shows promise in treating a milder form of depression disorder known as dysthymia, but in severe depression disorders its treatment results were unsatisfactory. Inpatients and outpatients suffering from depression are treated with this antidepressant drug.
Cases where the baby born from a woman who allegedly took the drug during her trimester suffered complications such as a birth defect has increased steadily. Fetal blood circulation of babies from women taking the drug has been found to have unnerving levels of the antidepressant drug. The placental barrier allows essential nutrients from the mother's blood circulation be transferred to the growing fetus but some harmful substances can also pass through the barrier if the molecular and chemical structures are met. Another serious complication linked with this drug is the increased likelihood of patients suffering from depression to entertain suicidal thoughts. That is why patients taking Zoloft are closely monitored for the first few drug administrations for signs and symptoms of psyche changes such as mood and behavior changes, anxiety, panic attacks, restlessness and other forms of suicidal ideation. If you are planning to stop taking Zoloft, better talk to your doctor first to prevent any complications.
An uproar arose as a consequence for the released advertising propaganda for this antidepressant drug which went like this:"While the cause is unknown, depression may be related to an imbalance of natural chemicals between nerve cells in the brain. Prescription Zoloft works to correct this imbalance. You just shouldn't have to feel this way anymore."The advertisement was met with critiques from medical professionals since the drug does not have sufficient evidence regarding its efficiency to treat depression disorders. The U.S. Food and Drug Administration issued a warning to the pharmaceutical company in response to the issue.
The results from the pre-marketing clinical trials conducted to test the new antidepressant drug Zoloft was met with unsatisfactory results. It was discovered in the placebo study that the drug shows promise in treating a milder form of depression disorder known as dysthymia, but in severe depression disorders its treatment results were unsatisfactory. Inpatients and outpatients suffering from depression are treated with this antidepressant drug.
Cases where the baby born from a woman who allegedly took the drug during her trimester suffered complications such as a birth defect has increased steadily. Fetal blood circulation of babies from women taking the drug has been found to have unnerving levels of the antidepressant drug. The placental barrier allows essential nutrients from the mother's blood circulation be transferred to the growing fetus but some harmful substances can also pass through the barrier if the molecular and chemical structures are met. Another serious complication linked with this drug is the increased likelihood of patients suffering from depression to entertain suicidal thoughts. That is why patients taking Zoloft are closely monitored for the first few drug administrations for signs and symptoms of psyche changes such as mood and behavior changes, anxiety, panic attacks, restlessness and other forms of suicidal ideation. If you are planning to stop taking Zoloft, better talk to your doctor first to prevent any complications.